A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2004
10/28/2004	US20040214826 Method of treating sexual disturbances
10/28/2004	US20040214825 Method of treating sexual disturbances
10/28/2004	US20040214824 treating sexual disorders using (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
10/28/2004	US20040214823 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione
10/28/2004	US20040214788 by administering an antagonist against one or more of the vitamin binding proteins riboflavin carrier protein, retinol binding protein, and folic acid binding protein
10/28/2004	US20040214781 Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
10/28/2004	US20040214780 Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
10/28/2004	US20040214779 complexes, expression vectors and host cells transformed or transfected with nucleic acid molecules encoding MAGE-C2; for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring
10/28/2004	US20040214778 Obesity treatment using synthetic, protected polypeptide
10/28/2004	US20040214777 Peptide activators of VEGF
10/28/2004	US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells
10/28/2004	US20040214775 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
10/28/2004	US20040214774 inhibiting accumulation of amyloid- beta deposits by administering an agent which inhibits interaction between amyloid- beta and proteins which chaperone amyloid- beta, such as alpha chymotrypsin or apolipoprotein E
10/28/2004	US20040214773 Methods and compositions for the inhibition of cathepsins
10/28/2004	US20040214772 aqueous solution of peptide YY receptor binding ligands or proteins, in sprayers for use in intranasal drug delivery
10/28/2004	US20040214771 Cleaved serum response factor in cardiac diagnosis and therapy
10/28/2004	US20040214770 Hemoactive compositions and methods for their manufacture and use
10/28/2004	US20040214767 Regulation of follicular development and ovulation by cytoskeletal genes and gene products
10/28/2004	US20040214766 administering vascular endothelial growth factors to promote cell proliferation and differentiation of neurons and prophylaxis of nervous system disorders
10/28/2004	US20040214765 Methods and means for inhibition of CDK4 activity
10/28/2004	US20040214763 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
10/28/2004	US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing
10/28/2004	US20040214760 Inhibition pf protein-phosphatases for the treatment of heart failure
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214758 polynucleotides that code for polypeptides having asparaginase activity, used for prevention of cell proliferation and cell differentiation, metabolic, cardiovascular and liver disorders, viral diseases and as immunology modulators
10/28/2004	US20040214756 administering mixtures of antithrombin and interleukins, tumor necrosis factors or enzyme inhibitors, for prophylaxis of infections
10/28/2004	US20040214755 cyclic depsipeptides and/or mimetics, used as anticarcinogenic agents, formed by cyclization of polypeptides
10/28/2004	US20040214754 Ophthalmic preparation containing glycomacropeptide
10/28/2004	US20040214751 Using anticoagulants/angiogenesis inhibitors/thrombolytic agents
10/28/2004	US20040214750 Medicaments for healing skin conditions in humans
10/28/2004	US20040214749 Compositions and methods for treatment of psoriasis
10/28/2004	US20040214748 Hemoglobin conjugates
10/28/2004	US20040214747 Method for administering monomeric insulin
10/28/2004	US20040214349 Molecular marker
10/28/2004	US20040214327 Nutrient broth comprising transition element ptoyrin complex complex for use in cell propagation
10/28/2004	US20040214325 Oligonucleotide sequences for use in controlling apolipoprotein expression and treatment of cardiovascular disorders; gene expression inhibition
10/28/2004	US20040214321 Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
10/28/2004	US20040214317 Nucleotide sequences coding membrane protein for use in treatment and prevention of anxiolytic, brain and nervous system disorders
10/28/2004	US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin
10/28/2004	US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214284 Isolated peptides which bind to MHC class II molecules, and uses thereof
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214280 Novel polypeptides and coagulation therapy
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004	US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004	US20040214257 Method for the treatment of vitamin D related disease
10/28/2004	US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004	US20040214231 Methods of testing for allergic diseases,and therapeutic agents for treating same
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders
10/28/2004	US20040214198 Allele-targeted RNA interference
10/28/2004	US20040214191 Nucleotide sequences coding ganosine triphosphatase ligand for use in diagnosis and treatment of cell proliferative disorders
10/28/2004	US20040214190 Mammalian c-type lectins
10/28/2004	US20040214189 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
10/28/2004	US20040214184 Amino acid sequences of carcinoembryonic antigen cell adhesion molecule for use as modulaor in treatment of cell proliferative disorders; mimetics
10/28/2004	US20040214182 Genetic modification of targeted regions of the cardiac conduction system
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004	US20040214163 Expression vector coding hepatitis c or lymphoma viral nucleotide sequences for use as tool in generating antibodies for use in kit which detects viral infection; vircides and immunotherapy
10/28/2004	US20040213855 Pharmaceutical composition for the treatment of acute disorders
10/28/2004	US20040213834 Pharmacological preparation made from a nanopatriculate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
10/28/2004	US20040213833 certain MMP inhibitory peptides improve the targeting of liposomes to cancer cells and enhance the uptake thereof by such cells
10/28/2004	US20040213829 Cleansing the body of heavy metals with a primary chelator to move a heavy metal species from the central nervous system into the vascular system; and a secondary chelator to capsure and move the metal into an excretion pathway.
10/28/2004	US20040213826 medical device for use in inhibiting proliferation and/or migration of smooth muscle cells, wherein the medical device has a coating comprising an HDAC inhibitor
10/28/2004	US20040213815 treating obsessions and compulsions, in particular skin picking, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin
10/28/2004	US20040213814 Therapeutic treatments for repetitive hand washing
10/28/2004	US20040213813 treating obsessions and compulsions, in particular head banging, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin
10/28/2004	US20040213812 Methods for treating trichotillomania
10/28/2004	US20040213811 Use of a botulinum neurotoxin to alleviate various disorders
10/28/2004	US20040213807 Use of Parapox B2L protein to modify immune responses to administered antigens
10/28/2004	US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
10/28/2004	US20040213802 Gene of novel corynebacterium diphtheriae antigen
10/28/2004	US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
10/28/2004	US20040213800 Active immunization to generate antibodies to soluble A-beta
10/28/2004	US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	US20040213796 Immunotherapy for chronic myelocytic leukemia
10/28/2004	US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis
10/28/2004	US20040213792 Method for inhibiting cellular activation by insulin-like growth factor-1
10/28/2004	US20040213790 VEGF-related protein
10/28/2004	US20040213789 Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
10/28/2004	US20040213787 Vascular Endothelial Growth Factors (VEGF) by injection; for decreased serum glucose concentrations, improved glucose tolerance, increased insulin sensitivity, and reduced hyperinsulinemia
10/28/2004	US20040213781 testing compounds for their ability to act as an Fc receptor antagonist; antagonist compounds identified by the method; detecting, removing immunoglobulin; rheumatoid arthritis
10/28/2004	US20040213780 Methods and compositions for treating polyglutamine expansion-associated disease
10/28/2004	US20040213778 a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; used to elicit a humoral or cellular immune response; antibodies or T cells reactive used in active or passive immunization
10/28/2004	US20040213776 Mycobacterium tuberculosis (MTB) targets for antibiotic therapy
10/28/2004	US20040213775 use of enzymes of the allene oxide synthase family for reducing myocardial ischemia reperfusion injury associated with myocardial infarction, thrombolysis, angioplasty and coronary bypass surgery
10/28/2004	US20040213774 Presbyopia treatment by lens alteration
10/28/2004	US20040213773 Composition and method for treating non-bacterial cystitis
10/28/2004	US20040213772 Peptide factor
10/28/2004	US20040213769 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
10/28/2004	US20040213764 Adenovirus replication-competent vectors expressing trail
10/28/2004	US20040213763 administering intravenously to the mammal an adenoviral vector comprising a DNA sequence encoding a leptin operably linked to a promoter and expressing the DNA sequence, for treating obesity in a mammal having a deficiency in functional leptin
10/28/2004	US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3

1 ... 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 ... 3163